Assertio Announces Restructuring Plan and Leadership Changes
“To adapt to the current market environment and maximize shareholder value, we are refocusing and substantially reducing our operating footprint, which is expected to result in significant cost savings,” said
The restructuring plan is expected to reduce Assertio’s total annual cost base by approximately
“We want to thank
About
Investor Contact
lroth@burnsmc.com
ir@assertiotx.com
Forward Looking Statements
Statements in this communication that are not historical facts are forward-looking statements that reflect Assertio’s current expectations, assumptions and estimates of future performance and economic conditions. These forward-looking statements are made in reliance on the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements relate to, among other things, future events or the future performance or operations of
Source: Assertio Therapeutics, Inc.
(COMMON STOCK)
Minimum 15 minutes delayed.